JP2018521077A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018521077A5 JP2018521077A5 JP2018503204A JP2018503204A JP2018521077A5 JP 2018521077 A5 JP2018521077 A5 JP 2018521077A5 JP 2018503204 A JP2018503204 A JP 2018503204A JP 2018503204 A JP2018503204 A JP 2018503204A JP 2018521077 A5 JP2018521077 A5 JP 2018521077A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- pharmaceutically acceptable
- pde4
- phosphodiesterase
- inhibitor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562198213P | 2015-07-29 | 2015-07-29 | |
| US62/198,213 | 2015-07-29 | ||
| PCT/EP2016/067968 WO2017017165A1 (en) | 2015-07-29 | 2016-07-28 | Pde4 inhibitor for the treatment of diabetic nephropathy |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2018521077A JP2018521077A (ja) | 2018-08-02 |
| JP2018521077A5 true JP2018521077A5 (enExample) | 2019-09-05 |
Family
ID=56551407
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018503204A Pending JP2018521077A (ja) | 2015-07-29 | 2016-07-28 | 糖尿病性腎症を治療するためのｐｄｅ４阻害剤 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20200179369A1 (enExample) |
| EP (1) | EP3328381A1 (enExample) |
| JP (1) | JP2018521077A (enExample) |
| CN (1) | CN108135886A (enExample) |
| BR (1) | BR112018001116A2 (enExample) |
| CA (1) | CA2992796A1 (enExample) |
| EA (1) | EA201890346A1 (enExample) |
| MA (1) | MA42519A (enExample) |
| WO (1) | WO2017017165A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2017317575B2 (en) * | 2016-08-26 | 2021-10-14 | Takeda Pharmaceutical Company Limited | Treatment of nonalcoholic fatty liver disease |
| CN119523985A (zh) * | 2017-05-27 | 2025-02-28 | 青岛海蓝医药有限公司 | 川芎嗪硝酮衍生物在预防和治疗糖尿病并发症疾病中的应用 |
| CN114053281B (zh) * | 2020-08-10 | 2025-05-27 | 成都文鼎科技发展有限公司 | 治疗慢性肾病的方法和药物组合物 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2005508358A (ja) * | 2001-10-25 | 2005-03-31 | デポメド・インコーポレイテッド | 胃滞留型ロサルタン投与量を用いる治療方法 |
| US7157584B2 (en) * | 2004-02-25 | 2007-01-02 | Takeda Pharmaceutical Company Limited | Benzimidazole derivative and use thereof |
| PT1723135E (pt) * | 2004-03-03 | 2013-08-29 | Takeda Gmbh | Novas hidroxi-6-heteroarilfenantridinas e sua utilização como inibidores de pde4 |
| GB0504103D0 (en) * | 2005-02-28 | 2005-04-06 | Syngenta Ltd | Novel method |
-
2016
- 2016-07-28 MA MA042519A patent/MA42519A/fr unknown
- 2016-07-28 EA EA201890346A patent/EA201890346A1/ru unknown
- 2016-07-28 WO PCT/EP2016/067968 patent/WO2017017165A1/en not_active Ceased
- 2016-07-28 US US15/746,560 patent/US20200179369A1/en not_active Abandoned
- 2016-07-28 EP EP16744758.0A patent/EP3328381A1/en not_active Withdrawn
- 2016-07-28 JP JP2018503204A patent/JP2018521077A/ja active Pending
- 2016-07-28 BR BR112018001116-9A patent/BR112018001116A2/pt not_active Application Discontinuation
- 2016-07-28 CN CN201680056550.2A patent/CN108135886A/zh active Pending
- 2016-07-28 CA CA2992796A patent/CA2992796A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013535487A5 (enExample) | ||
| JP2021509912A5 (enExample) | ||
| JP2012533546A5 (enExample) | ||
| EA201100613A1 (ru) | Конденсированные, спироциклические гетероароматические соединения для лечения бактериальных инфекций | |
| JP2014505107A5 (enExample) | ||
| JP2010265321A5 (enExample) | ||
| JP2017518334A5 (enExample) | ||
| JP2013510124A5 (enExample) | ||
| JP2011522816A5 (enExample) | ||
| JP2011502958A5 (enExample) | ||
| JP2014513110A5 (enExample) | ||
| JP2010222367A5 (enExample) | ||
| JP2006517944A5 (enExample) | ||
| JP2020536919A5 (enExample) | ||
| JP2012507535A5 (enExample) | ||
| JP2017517538A5 (enExample) | ||
| JP2009538861A5 (enExample) | ||
| JP2016512817A5 (enExample) | ||
| RU2009111378A (ru) | Терапевтические композиции, содержащие специфический антагонист рецептора эндотелина и ингибиторов pde5 | |
| JP2015526455A5 (enExample) | ||
| JP2018521077A5 (enExample) | ||
| JP2017509611A5 (enExample) | ||
| JP2009518415A5 (enExample) | ||
| JP2016512541A5 (enExample) | ||
| CN110023286A (zh) | 作为ccr2/ccr5受体拮抗剂的联苯化合物 |